Taiwan's National Health Insurance program was initiated in March 1995, and it now covers more than 99% of Taiwan's 23 million residents. In this study, we used reimbursement claims data from Taiwan's National Health Insurance Research Database, which records patients' basic characteristics and medical services. This information includes physicians' primary and secondary diagnoses, treatment, procedures, prescriptions, the medical expenses of outpatient care, emergency care, and hospitalizations \[14-16\]. The data underlying this study is from the National Health Insurance Research Database, which has been transferred to the Health and Welfare Data Science Center. Interested researchers can obtain the data through formal application to the Health and Welfare Data Science Center, Department of Statistics, Ministry of Health and Welfare, Taiwan (<http://dep.mohw.gov.tw/DOS/np-2497-113.html>). Under the regulations from the National Health Insurance Research Institutes, we have made the formal application (included application documents, study proposals, and ethics approval of the institutional review board) of the current insurance data from in 2015. The authors of the present study had no special access privileges in accessing the data which other interested researchers would not have.

Introduction {#sec005}
============

Fractures are an important public health problem that affects populations all over the world, especially hip fractures. The annual mean number of hip fractures was 957.3 per 100,000 for women and 414.4 per 100,000 for men in the United States \[[@pone.0231374.ref001]\]. A typical patient with a hip fracture spends US \$40000 in the first year following a hip fracture for direct medical costs and almost \$5000 in subsequent years \[[@pone.0231374.ref001]\]. Mortality, morbidity and a poor recovery after a fracture not only affect a patient's activities of daily living but also cost a significant amount of money in medical expenses. Therefore, post-fracture outcomes and factors that affect the prognosis are important.

Some studies have found no differences in fracture outcome between genders \[[@pone.0231374.ref002],[@pone.0231374.ref003]\]. A Finnish study has reported worse survival after fracture in female patients than in male patients \[[@pone.0231374.ref004]\]. In contrast, several previous studies have shown gender differences in short-term and long-term mortality, adverse outcomes and post-fracture functional recovery, mostly indicating that men, for unknown reasons, tend to have worse post-fracture outcomes than women \[[@pone.0231374.ref005]--[@pone.0231374.ref013]\]. However, many of the previous studies were limited by a small sample size \[[@pone.0231374.ref007]--[@pone.0231374.ref009],[@pone.0231374.ref013]\], an absence of adequate matching \[[@pone.0231374.ref005],[@pone.0231374.ref006],[@pone.0231374.ref008],[@pone.0231374.ref009],[@pone.0231374.ref011]--[@pone.0231374.ref013]\], and by focusing on single type of fracture \[[@pone.0231374.ref005]--[@pone.0231374.ref013]\] or a specific population \[[@pone.0231374.ref003],[@pone.0231374.ref005],[@pone.0231374.ref008]--[@pone.0231374.ref010]\]. These limitations made the interpretation about the association between gender and outcomes inconclusive and incompletely understood. In addition, limited information was available on the sex differences of fracture outcomes in Taiwan populations.

Using Taiwan\'s National Health Insurance Research Database, we conducted a nationwide matched cohort study that included all fracture patients from 2008--2013. The aim of our study was to compare the post-fracture complications of women and men.

Methods {#sec006}
=======

Source of data {#sec007}
--------------

Taiwan's National Health Insurance program was initiated in March 1995, and it now covers more than 99% of Taiwan's 23 million residents. In this study, we used reimbursement claims data from Taiwan's National Health Insurance Research Database, which records patients' basic characteristics and medical services. This information includes physicians' primary and secondary diagnoses, treatment, procedures, prescriptions, the medical expenses of outpatient care, emergency care, and hospitalizations \[[@pone.0231374.ref014]--[@pone.0231374.ref016]\].

The data underlying this study is from the National Health Insurance Research Database, which has been transferred to the Health and Welfare Data Science Center. Interested researchers can obtain the data through formal application to the Health and Welfare Data Science Center, Department of Statistics, Ministry of Health and Welfare, Taiwan (<http://dep.mohw.gov.tw/DOS/np-2497-113.html>). Under the regulations from the National Health Insurance Research Institutes, we have made the formal application (included application documents, study proposals, and ethics approval of the institutional review board) of the current insurance data from in 2015. The authors of the present study had no special access privileges in accessing the data which other interested researchers would not have.

Ethics approval {#sec008}
---------------

As these reimbursement claims were used in this study, the electronic database was decoded with patient identifications scrambled for further academic access for research to protect privacy. We conducted this study in accordance with the Declaration of Helsinki. Although the National Health Research Institutes exempt such uses from informed consent, because patient identifications are decoded and scrambled, this study was evaluated and approved by the Institutional Review Board of Taipei Medical University (TMU-JIRB-201404070; TMU-JIRB-201505055; TMU-JIRB-201705084).

Study design {#sec009}
------------

Among the \>3 million surgical patients over 20 years of age in Taiwan between 2008 and 2013, we identified 498,586 patients with a fracture-related hospitalization. For the comparison of fracture outcomes between women and men, each female fracture patient was randomly matched to a male fracture patient, using a propensity score matched-pair procedure to balance the differences in baseline characteristics. After propensity score matching (case-control ratio, 1:1), there were 100,864 female patients and 100,864 male patients.

Measures and definitions {#sec010}
------------------------

According to the regulations from the Bureau of National Health Insurance in Taiwan, people with low-income status were qualified to have the registration fee and medical copayment waived when they received outpatient, emergency, and inpatient medical care. In this study, low socioeconomic status was defined as a patient who had a record of a waived registration fee and medical copayment due to low income during the 2 years prior to the fracture-related hospitalization. We used *The International Classification of Diseases*, *Ninth Revision*, *Clinical Modification* (ICD-9-CM) and physicians' diagnoses to identify patients' history of diseases. Based on our previous studies, pre-fracture medical conditions that were identified via medical claims for the 24-month pre-fracture period included hypertension (ICD-9-CM 401--405), hyperlipidemia (ICD-9-CM 272.0, 272.1, and 272.2), peptic ulcer disease (ICD-9-CM 531--533), diabetes (ICD-9-CM 250), mental disorders (ICD-9-CM 290--319), ischemic heart disease (ICD-9-CM 410--414), atherosclerosis (ICD-9-CM 440), chronic obstructive pulmonary disease (ICD-9- CM 491,492, 496), anemia (ICD-9-CM 280--285), heart failure (ICD-9-CM 428), chronic kidney disease (ICD-9-CM 580--585), cancer (ICD-9-CM 140--208), osteoporosis (ICD-9-CM 733.0), stroke (ICD-9-CM 430--438), and liver cirrhosis (ICD-9-CM 571.2, 571.5, 571.6). Renal dialysis was identified by an administration code (D8, D9). Nine major in-hospital complications after fracture were noted, including pulmonary embolism (ICD-9-CM 415), stroke (ICD-9-CM 430--438), pneumonia (ICD-9-CM 480--486), urinary tract infection (ICD-9-CM 599.0), septicemia (ICD-9-CM 038, 998.5), acute renal failure (ICD-9-CM584), postoperative bleeding (ICD-9-CM 998.0, 998.1 and 998.2), acute myocardial infarction (ICD-9-CM 410), and deep wound infection (ICD-9-CM 958.3). Length of hospital stay and medical expenditures after the initial fracture admission were analyzed as secondary outcomes, and differences were noted between female and male patients. The 30-day in-hospital mortality is the main outcome of this study. Fracture patient's medical expenditure was calculated by accounting all National Health Insurance payment during the index fracture hospitalization included surgical procedures, medications, admission stay, and materials. However, self-payment expenditure (out-off pocket money) was not included in this study.

Statistical analysis {#sec011}
--------------------

To reduce confounding errors, this study used a propensity score-matched pair procedure to balance the covariates between female fracture patients and male fracture patients. We developed a non-parsimonious multivariable logistic regression model to estimate a propensity score for female and male fracture patients. Clinical significance guided the initial choice of covariates in this model. Covariates included age, low income, medical condition, and type of fracture. A structured iterative approach was used to refine this model with the goal of achieving a covariate balance within the matched pairs. We used chi-square tests to measure covariate balance, and p \< 0.05 was used to represent a meaningful covariate imbalance. We matched female patients to male patients using a greedy matching algorithm with a caliper width of 0.2 standard deviation of the log odds of the estimated propensity score \[[@pone.0231374.ref017]--[@pone.0231374.ref019]\].

Adjusted odds ratios (OR) with 95% confidence intervals (CI) for 30-day complications and mortality after fracture between female and male patients were calculated in the multivariate logistic regression models by adjusting for age, low-income, medical conditions, and type of fracture. We also performed stratification analysis by age, coexisting medical conditions, and type of fracture for the risk of post-fracture adverse events (including 30-day in-hospital mortality, stroke, pneumonia, septicemia, acute renal failure, acute myocardial infarction, and deep wound infection) associated with sex. SAS version 9.1 (SAS Institute Inc., Cary, NC) statistical software was used for data analyses; 2-sided p \< 0.05 indicated statistically significant differences.

Results {#sec012}
=======

Before matching with propensity scores ([Table 1](#pone.0231374.t001){ref-type="table"}), male fracture patients had higher proportions of young age of 20--29 years (p \< 0.0001), low income (p \< 0.0001), skull bone fracture (p \< 0.0001), chronic obstructive pulmonary disease (p \< 0.0001), and liver cirrhosis (p \< 0.0001). However, male fracture patients had lower proportions of hypertension (p \< 0.0001), hyperlipidemia (p \< 0.0001), peptic ulcer disease (p \< 0.0001), diabetes (p \< 0.0001), mental disorders (p \< 0.0001), ischemic heart disease (p \< 0.0001), atherosclerosis (p \< 0.0001), anemia (p \< 0.0001), heart failure (p \< 0.0001), and renal dialysis (p \< 0.0001). After matching with propensity scores ([Table 2](#pone.0231374.t002){ref-type="table"}), there were no differences in age, medical conditions, fracture type, and history of emergency care and hospitalization between female and male patients.

10.1371/journal.pone.0231374.t001

###### Baseline characteristics in female and male fracture patients before matching.

![](pone.0231374.t001){#pone.0231374.t001g}

                                                                    Female (n = 249012)   Male (n = 249574)   p                 
  ----------------------------------------------------------------- --------------------- ------------------- -------- -------- ----------
  Age, years                                                        n                     (%)                 n        (%)      \<0.0001
      20--29                                                        18582                 (7.5)               44607    (17.9)   
      30--39                                                        17066                 (6.9)               40456    (16.2)   
      40--49                                                        23655                 (9.5)               43903    (17.6)   
      50--59                                                        46832                 (18.8)              40764    (16.3)   
      60--69                                                        45149                 (18.1)              26091    (10.5)   
      70--79                                                        52236                 (21.0)              26683    (10.7)   
      ≥80                                                           45492                 (18.3)              27070    (10.9)   
  Low income                                                                                                                    \<0.0001
      No                                                            243314                (97.7)              241805   (96.9)   
      Yes                                                           5698                  (2.3)               7769     (3.1)    
  Types of fracture                                                                                                             \<0.0001
      Skull                                                         2509                  (1.0)               8027     (3.2)    
      Face bones                                                    7493                  (3.0)               13988    (5.6)    
      Unqualified skull fracture                                    618                   (0.3)               2204     (0.9)    
      Vertebral column                                              13445                 (5.4)               9973     (4.0)    
      Rib, sternum, larynx or trachea                               1976                  (0.8)               4539     (1.8)    
      Pelvis                                                        1729                  (0.7)               2258     (0.9)    
      Other ill-defined fractures of trunk                          3                     (0.0)               1        (0.0)    
      Clavicle or scapula                                           14061                 (5.7)               25743    (10.3)   
      Humerus, radius or ulna                                       76446                 (30.7)              48697    (19.5)   
      Carpal, metacarpal, or phalanges                              7550                  (3.0)               21041    (8.4)    
      Other upper limb                                              3                     (0.0)               9        (0.0)    
      Fracture of femur                                             67951                 (27.3)              46733    (18.7)   
      Fracture of patella, tibia, or fibula                         27603                 (11.1)              31760    (12.7)   
      Ankle, tarsal, metatarsal bones, phalanges of foot            27424                 (11.0)              34217    (13.7)   
      Other lower limb                                              26                    (0.01)              36       (0.01)   
      Multiple fractures of upper limbs, lower limbs or trunk       174                   (0.1)               342      (0.1)    
      Fracture of unspecified bones                                 1                     (0.0)               6        (0.0)    
  Fracture with surgery                                             176588                (70.9)              185034   (74.1)   \<0.0001
  Medical conditions                                                                                                            
      Hypertension                                                  116198                (46.7)              74303    (29.8)   \<0.0001
      Mental disorders                                              50508                 (20.3)              35379    (14.2)   \<0.0001
      Diabetes                                                      56162                 (22.6)              33988    (13.6)   \<0.0001
      Hyperlipidemia                                                56317                 (22.6)              31595    (12.7)   \<0.0001
      Peptic ulcer disease                                          27841                 (11.2)              21716    (8.7)    \<0.0001
      COPD                                                          15387                 (6.2)               20760    (8.3)    \<0.0001
      Ischemic heart disease                                        25223                 (10.1)              17374    (7.0)    \<0.0001
      Atherosclerosis                                               18271                 (7.3)               12759    (5.1)    \<0.0001
      Anemia                                                        19319                 (7.8)               10117    (4.1)    \<0.0001
      Heart failure                                                 11142                 (4.5)               6421     (2.6)    \<0.0001
      Liver cirrhosis                                               2203                  (0.9)               3553     (1.4)    \<0.0001
      Renal dialysis                                                4310                  (1.7)               2919     (1.2)    \<0.0001
      Chronic kidney disease                                        6736                  (2.7)               5179     (2.1)    \<0.0001
      Asthma                                                        13050                 (5.2)               8763     (3.5)    \<0.0001
      Stroke                                                        7505                  (3.0)               6474     (2.6)    \<0.0001
      Cancer                                                        12231                 (4.9)               9184     (3.7)    \<0.0001
      Osteoporosis                                                  13280                 (5.3)               2756     (1.1)    \<0.0001
      Alcohol-related illness                                       1773                  (0.7)               9390     (3.8)    \<0.0001
      Parkinson\'s disease                                          6616                  (2.7)               4297     (1.7)    \<0.0001
  Number of hospitalizations[\*](#t001fn002){ref-type="table-fn"}                                                               \<0.0001
      0                                                             204202                (82.0)              208629   (83.6)   
      1                                                             29467                 (11.8)              25947    (10.4)   
      2                                                             8674                  (3.5)               7967     (3.2)    
      ≥3                                                            6669                  (2.7)               7031     (2.8)    
  Number of emergency visits[\*](#t001fn002){ref-type="table-fn"}                                                               \<0.0001
      0                                                             147898                (59.4)              145488   (58.3)   
      1                                                             61665                 (24.8)              63513    (25.5)   
      2                                                             21878                 (8.8)               23055    (9.2)    
      ≥3                                                            17571                 (7.1)               17518    (7.0)    

COPD, chronic obstructive pulmonary disease.

\*Before fracture admission within one year

10.1371/journal.pone.0231374.t002

###### Baseline characteristics in female and male fracture patients after matching.

![](pone.0231374.t002){#pone.0231374.t002g}

                                                                   Female (n = 100864)   Male (n = 100864)            
  ---------------------------------------------------------------- --------------------- ------------------- -------- --------
      20--29                                                       14965                 (14.8)              14965    (14.8)
      30--39                                                       12206                 (12.1)              12206    (12.1)
      40--49                                                       15635                 (15.5)              15635    (15.5)
      50--59                                                       24800                 (24.6)              24800    (24.6)
      60--69                                                       12237                 (12.1)              12237    (12.1)
      70--79                                                       10112                 (10.0)              10112    (10.0)
      ≥80                                                          10909                 (10.8)              10909    (10.8)
  Low income                                                                                                          
      No                                                           99769                 (98.9)              99769    (98.9)
      Yes                                                          1095                  (1.1)               1095     (1.1)
  Types of fracture[\*](#t002fn002){ref-type="table-fn"}                                                              
      Skull                                                        1391                  (1.4)               1391     (1.4)
      Face bones                                                   4872                  (4.8)               4872     (4.8)
      Unqualified skull fracture                                   281                   (0.3)               281      (0.3)
      Vertebral column                                             3093                  (3.1)               3093     (3.1)
      Rib, sternum, larynx or trachea                              684                   (0.7)               684      (0.7)
      Pelvis                                                       544                   (0.5)               544      (0.5)
      Clavicle or scapula                                          9420                  (9.3)               9420     (9.3)
      Humerus, radius or ulna                                      25991                 (25.8)              25991    (25.8)
      Carpal, metacarpal, or phalanges                             4962                  (4.92)              4962     (4.9)
      Other upper limb                                             0                     (0.0)               0        (0.0)
      Fracture of femur                                            19281                 (19.1)              19281    (19.1)
      Fracture of patella, tibia, or fibula                        14702                 (14.6)              14702    (14.6)
      Ankle, tarsal, metatarsal bones, phalanges of foot           15583                 (15.5)              15583    (15.5)
      Other lower limb                                             1                     (0.0)               1        (0.0)
      Multiple fractures of upper limbs, lower limbs or trunk      59                    (0.1)               59       (0.1)
  Fracture with surgery                                            89500                 (78.8)              89500    (78.8)
  Medical conditions                                                                                                  
      Hypertension                                                 33221                 (29.2)              33221    (29.2)
      Diabetes                                                     13693                 (12.1)              13693    (12.1)
      Hyperlipidemia                                               13863                 (12.2)              13863    (12.2)
      Mental disorders                                             12459                 (11.0)              12459    (11.0)
      Peptic ulcer disease                                         6226                  (5.5)               6226     (5.5)
      Ischemic heart disease                                       3987                  (3.5)               3987     (3.5)
      COPD                                                         3436                  (3.0)               3436     (3.0)
      Atherosclerosis                                              2607                  (2.3)               2607     (2.3)
      Anemia                                                       2008                  (1.8)               2008     (1.8)
      Heart failure                                                881                   (0.8)               881      (0.8)
      Renal dialysis                                               237                   (0.2)               237      (0.2)
      Liver cirrhosis                                              179                   (0.2)               179      (0.2)
      Chronic kidney disease                                       440                   (0.4)               440      (0.4)
      Asthma                                                       2036                  (1.8)               2036     (1.8)
      Stroke                                                       798                   (0.7)               798      (0.7)
      Cancer                                                       2049                  (1.8)               2049     (1.8)
      Osteoporosis                                                 704                   (0.6)               704      (0.6)
      Alcohol-related illness                                      577                   (0.5)               577      (0.5)
      Parkinson\'s disease                                         815                   (0.7)               815      (0.7)
  Number of hospitalizations[†](#t002fn003){ref-type="table-fn"}                                                      
      0                                                            104468                (91.9)              104468   (91.9)
      1                                                            7788                  (6.9)               7788     (6.9)
      2                                                            931                   (0.8)               931      (0.8)
      ≥3                                                           438                   (0.4)               438      (0.4)
  Number of emergency visits[†](#t002fn003){ref-type="table-fn"}                                                      
      0                                                            74908                 (65.9)              74908    (65.9)
      1                                                            28007                 (24.7)              28007    (24.7)
      2                                                            7536                  (6.6)               7536     (6.6)
      ≥3                                                           3174                  (2.8)               3174     (2.8)

COPD, chronic obstructive pulmonary disease.

\*After matching by propensity score, there is no patients in other ill-defined fractures of trunk, other upper limb, and fracture of unspecified bones.

†Before fracture admission within one year

Compared with women (after matching procedure in [Table 3](#pone.0231374.t003){ref-type="table"}), men had higher risks of post-fracture mortality (OR1.40, 95% CI 1.19--1.64) and complications, including pneumonia (OR 1.77, 95% CI 1.62--1.93), acute renal failure (OR 1.60, 95% CI 1.33--1.91), deep wound infection (OR 1.60, 95% CI 1.47--1.75), stroke (OR 1.59, 95% CI 1.49--1.70), septicemia (OR 1.53, 95% CI 1.42--1.64) and acute myocardial infarction (OR 1.57, 95% CI 1.16--2.12). Longer length of hospital stays (6.6±6.3 vs. 6.2±5.7 days, p \< 0.0001) and increased medical expenditures (1743±1797 vs. 1672±1589 US dollars, p \< 0.0001) were also noted in the male patients. However, lower risk of urinary tract infection after fracture was found in men compared with women (OR 0.64, 95% CI 0.60--0.68).

10.1371/journal.pone.0231374.t003

###### Risk of complications and mortality after fracture for female and male patients.

![](pone.0231374.t003){#pone.0231374.t003g}

                                                                        Female (n = 100864)   Male (n = 100864)   Risk of outcomes                
  --------------------------------------------------------------------- --------------------- ------------------- ------------------ ----- ------ --------------
  30-day in-hospital mortality                                          278                   0.3                 381                0.4   1.40   (1.19--1.64)
  Postoperative complications                                                                                                                     
      Pneumonia                                                         851                   0.8                 1456               1.4   1.77   (1.62--1.93)
      Acute renal failure                                               198                   0.2                 314                0.3   1.60   (1.33--1.91)
      Deep wound infection                                              836                   0.8                 1329               1.3   1.60   (1.47--1.75)
      Stroke                                                            1648                  1.6                 2514               2.5   1.59   (1.49--1.70)
      Septicemia                                                        1198                  1.2                 1811               1.8   1.53   (1.42--1.64)
      Acute myocardial infarction                                       70                    0.1                 109                0.1   1.57   (1.16--2.12)
      Postoperative bleeding                                            149                   0.2                 171                0.2   1.15   (0.92--1.43)
      Pulmonary embolism                                                65                    0.1                 74                 0.1   1.14   (0.81--1.59)
      Urinary tract infection                                           2826                  2.8                 1870               1.9   0.64   (0.60--0.68)
  Medical expenditure, US dollars[†](#t003fn003){ref-type="table-fn"}   1672±1589             1743±1797           p\<0.0001                       
  Length of hospital stay, days[†](#t003fn003){ref-type="table-fn"}     6.2±5.7               6.6±6.3             p\<0.0001                       

CI, confidence interval; OR, odds ratio.

\*Adjusted for all covariates listed in [Table 2](#pone.0231374.t002){ref-type="table"}.

†Mean±standard deviation. For the medical expenditure, the median and interquartile range were 1328 (954--2073) in men and 1308 (950--2051) in women; For the length of hospital stay, the median and interquartile range were 5 (3--8) in men and 5 (3--7) in women.

In [Table 4](#pone.0231374.t004){ref-type="table"}, the association between male gender and the risk of post-fracture adverse events was significant in patients aged 40--49 years (OR 1.20, 95% CI 1.07--1.34), 50--59 years (OR 1.23, 95% CI 1.13--1.34), 60--69 years (OR 1.38, 95% CI 1.25--1.51), 70--79 years (OR 1.39, 95% CI 1.29--1.51), and ≥80 years (OR 1.69, 95% CI 1.58--1.81). Male gender was associated with increased risk of adverse events after fracture in patients with zero (OR 1.24, 95% CI 1.17--1.32), one (OR 1.25, 95% CI 1.17--1.34), two (OR 1.24, 95% CI 1.14--1.33), more than three (OR 1.19, 95% CI 1.10--1.28) documented medical conditions. Post-fracture adverse events were associated with male gender for patients with various subtypes of fracture.

10.1371/journal.pone.0231374.t004

###### The stratified analysis for the risk of adverse events after fracture associated with sex.
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                                                                     Adverse events[\*](#t004fn002){ref-type="table-fn"}                        
  --------------------------------------------------------- -------- ----------------------------------------------------- ------ ------ ------ --------------
  Age 20--29 years                                          Female   14965                                                 536    3.6    1.00   (reference)
                                                            Male     14965                                                 564    3.8    1.06   (0.93--1.20)
  Age 30--39 years                                          Female   12206                                                 454    3.7    1.00   (reference)
                                                            Male     12206                                                 461    3.8    1.02   (0.89--1.17)
  Age 40--49 years                                          Female   15635                                                 595    3.8    1.00   (reference)
                                                            Male     15635                                                 699    4.5    1.20   (1.07--1.34)
  Age 50--59 years                                          Female   24800                                                 1113   4.5    1.00   (reference)
                                                            Male     24800                                                 1342   5.4    1.23   (1.13--1.34)
  Age 60--69 years                                          Female   12237                                                 854    7.0    1.00   (reference)
                                                            Male     12237                                                 1124   9.2    1.38   (1.25--1.51)
  Age 70--79 years                                          Female   10112                                                 1270   12.6   1.00   (reference)
                                                            Male     10112                                                 1668   16.5   1.39   (1.29--1.51)
  Age ≥80 years                                             Female   10909                                                 2169   19.9   1.00   (reference)
                                                            Male     10909                                                 2471   22.7   1.18   (1.11--1.26)
  0 medical condition                                       Female   55426                                                 2250   4.1    1.00   (reference)
                                                            Male     55426                                                 2725   4.9    1.24   (1.17--1.32)
  1 medical condition                                       Female   21953                                                 1789   8.2    1.00   (reference)
                                                            Male     21953                                                 2156   9.8    1.25   (1.17--1.34)
  2 medical conditions                                      Female   13121                                                 1467   11.2   1.00   (reference)
                                                            Male     13121                                                 1743   13.3   1.24   (1.14--1.33)
  ≥3 medical conditions                                     Female   10364                                                 1485   14.3   1.00   (reference)
                                                            Male     10364                                                 1705   16.5   1.19   (1.10--1.28)
  Fracture of skull                                         Female   1391                                                  526    37.8   1.00   (reference)
                                                            Male     1391                                                  512    36.8   0.96   (0.82--1.12)
  Fracture of face bones                                    Female   4872                                                  99     2.0    1.00   (reference)
                                                            Male     4872                                                  146    3.0    1.50   (1.15--1.94)
  Other skull fracture                                      Female   281                                                   110    39.2   1.00   (reference)
                                                            Male     281                                                   118    42.0   1.14   (0.80--1.62)
  Vertebral column                                          Female   3093                                                  311    10.1   1.00   (reference)
                                                            Male     3093                                                  426    13.8   1.44   (1.23--1.68)
  Rib, sternum, larynx and trachea                          Female   684                                                   49     7.2    1.00   (reference)
                                                            Male     684                                                   72     10.5   1.56   (1.06--2.31)
  Pelvis                                                    Female   544                                                   65     12.0   1.00   (reference)
                                                            Male     544                                                   72     13.2   1.13   (0.78--1.64)
  Clavicle or scapula                                       Female   9420                                                  193    2.1    1.00   (reference)
                                                            Male     9420                                                  200    2.1    1.04   (0.85--1.27)
  Humerus, radius or ulna                                   Female   25991                                                 886    3.4    1.00   (reference)
                                                            Male     25991                                                 1072   4.1    1.22   (1.12--1.34)
  Carpal, metacarpal, or phalanges                          Female   4962                                                  152    3.1    1.00   (reference)
                                                            Male     4962                                                  137    2.8    0.90   (0.71--1.14)
  Fracture of femur                                         Female   19281                                                 3187   16.5   1.00   (reference)
                                                            Male     19281                                                 3847   20.0   1.27   (1.20--1.34)
  Patella, tibia, or fibula                                 Female   14702                                                 772    5.3    1.00   (reference)
                                                            Male     14702                                                 1037   7.1    1.37   (1.25--1.51)
  Ankle, tarsal and metatarsal bones, phalanges of foot     Female   15583                                                 640    4.1    1.00   (reference)
                                                            Male     15583                                                 687    4.4    1.08   (0.97--1.20)
  Multiple fractures of upper limbs, lower limbs or trunk   Female   59                                                    1      1.7    1.00   (reference)
                                                            Male     59                                                    3      5.1    3.49   (0.32--38.4)
  Fracture without surgery                                  Female   20920                                                 2512   12.0   1.00   (reference)
                                                            Male     20920                                                 2974   14.2   1.24   (1.17--1.32)
  Fracture with surgery                                     Female   79944                                                 4479   5.6    1.00   (reference)
                                                            Male     79944                                                 5355   6.7    1.23   (1.18--1.28)

CI, confidence interval; OR, odds ratio.

\*Adverse events included with 30-day in-hospital mortality, stroke, pneumonia, septicemia, acute renal failure, acute myocardial infarction, deep wound infection, postoperative bleeding, pulmonary embolism, urinary tract infection.

†Adjusted for all covariates listed in [Table 2](#pone.0231374.t002){ref-type="table"}.

Discussion {#sec013}
==========

This nationwide, propensity score-matched, retrospective population-based study showed that male gender was independently associated with higher post-fracture 30-day in-hospital mortality, complications (including stroke, acute renal failure, and acute myocardial infarction), and infectious conditions (such as pneumonia, septicemia and deep wound infection). Increased medical expenditures and longer length of hospital stays were also noted in males compared to females.

Several previous investigations have tried to determine the association between sex differences and post-fracture mortality rates. Most studies reported a higher long-term (\>120 days) post-fracture mortality rate among men \[[@pone.0231374.ref006],[@pone.0231374.ref008],[@pone.0231374.ref009],[@pone.0231374.ref020],[@pone.0231374.ref021],[@pone.0231374.ref022]\], which is consistent with our study result. Our study showed that male patients have higher 30-day in-hospital mortality rate, compared with female patients. We analyzed 30-day in-hospital mortality, a relatively short-term cut point, instead of a long-term cut point as previous researchers did in order to further reinforce the relationship between fractures and mortality.

Several studies suggested male gender as a risk factor for major infection in post-fracture and trauma populations \[[@pone.0231374.ref023],[@pone.0231374.ref024]\], and more male patients suffer from severe sepsis or septic shock in surgical intensive care units \[[@pone.0231374.ref025]\]. Similar to previous studies, we noted that male patients had higher incidences of post-fracture pneumonia, deep wound infections, and septicemia, while female patients had a higher incidence of urinary tract infections. Mounting evidence in both animal and human studies showed that sex hormones play a role in immunomodulation, which could affect the incidence and severity of infections \[[@pone.0231374.ref026]--[@pone.0231374.ref030]\], suggesting a reasonable explanation as to why female patients may tolerate sepsis better. Splenocyte proliferative capacity and splenocyte interlukin-2 and interlukin-3 responses were remarkably decreased in male septic mice, leading to decreased survival rates \[[@pone.0231374.ref027]\]. Human studies showed higher levels of a pro-inflammatory mediator (tumor necrosis factor alpha) in men than women, and lower levels of an anti-inflammatory mediator (interlukin-10) in women \[[@pone.0231374.ref029]\], demonstrating the different immune reactions between genders during sepsis.

In our study, post-fracture infections may account for longer hospital stays, higher medical expenditures, and higher mortality rates. One research has demonstrated that post-hip fracture chest infection may contribute to 30-day mortality, while deep wound infection and urinary tract infection did not \[[@pone.0231374.ref031]\]. Another study using adjusted logistic regression model analysis concluded that mortality rates were similar between males and females after excluding deaths caused by infections \[[@pone.0231374.ref023]\]. The fact that men and women have different incidences and severities of infectious diseases should be of greater clinical importance, as it may affect the prognosis significantly.

Post-fracture stroke rate was noted to be higher in men than women. According to previous research, the incidence of stroke is lower in women who are less than 85 years of age, and the first stroke event tends to occur at an older age \[[@pone.0231374.ref032],[@pone.0231374.ref033]\]. This may be explained by the neuroprotective effects of estrogen and progesterone \[[@pone.0231374.ref034]--[@pone.0231374.ref036]\]. Estrogen mediates its neuroprotective effect through several mechanisms, including its antioxidant effect, the preservation of autoregulation functions, and decreased cell apoptosis. Progesterone has an effect on membrane stabilization and decreasing cell excitotoxicity through glutamate receptor inhibition \[[@pone.0231374.ref034]\]. The neuronal preservation tends to be better in women than men after ischemic events \[[@pone.0231374.ref035],[@pone.0231374.ref036]\].

The data also showed higher acute myocardial infarction rates in men than women. Estrogen is known to have a cardioprotective effect through various mechanisms \[[@pone.0231374.ref037]\], thus it is not surprising that previous research has already revealed a gender gap in the risk of myocardial infarction and other cardiovascular diseases \[[@pone.0231374.ref038]--[@pone.0231374.ref040]\]. The incidence of acute renal failure is also higher in men. However, we were unable to obtain information about pre-fracture renal function, medications, and fluid administration via our database, so careful interpretation of this finding is warranted.

Longer hospital stays and increased medical expenditures in male patients were likely due to them experiencing a greater number of adverse events. Other factors that have post-fracture gender differences and might have influenced post-fracture hospital stays and expenses include post-fracture functional status, rehabilitation conditions, and the patients' socioeconomic support \[[@pone.0231374.ref041]--[@pone.0231374.ref044]\]. Future studies may focus on post-fracture care since this issue may be important to integrated care and cost-savings.

We performed subgroup analyses, which were stratified according to age, number of medical conditions and previous fracture locations. The rate of adverse events shows significant differences among age groups, and the differences tend to be greater as age increases. Additionally, this gender difference is still prominent after accounting for the number of medical conditions and different fracture locations. In addition, we also observed that the gender difference exists in both fracture patients who underwent orthopedic surgery and those who did not. However, this phenomenon was first reported in the present study.

Our study has some limitations. First, our database lacks information about patients' sociodemographics and lifestyles, as well as their detailed clinical conditions, including pre-fracture and post-fracture physical function, perioperative findings and in-hospital laboratory examinations. Second, we used claimed ICD-9-CM codes, which could not demonstrate the severity of comorbid illnesses, or the mechanism of the injuries. Third, the validation of Taiwan's National Health Insurance Research Database remains inadequate although the physician's diagnosis and codes of diseases were validated in previous studies \[[@pone.0231374.ref045]--[@pone.0231374.ref051]\]. Fourth, the information of diagnosis-related group and self-payment was not available in the insurance database in Taiwan. It is also a limitation that we could not evaluate the influence of diagnosis-related group and expensive self-payment orthopedic instrument on the medical expense and length of hospital stay. In addition, the American Society of Anesthesiologists grade is a good indicator for determining general health status. However, it is not available in Taiwan's National Insurance Research Database. Finally, although we performed propensity score matching and multivariate adjustment, some residual confounding bias remains possible. There were many potential confounding factors were not considered in this study.

In conclusion, we raised the possibility that men had more complications and higher mortality than women, with the exception of increased rates of urinary tract infections in women. This phenomenon could be observed in the subgroup analysis. However, the interpretation of our findings should be cautioned because of several study limitation.

This study is based in part on data obtained from Taiwan's Ministry of Health and Welfare. The authors' interpretations and conclusions do not represent Taiwan's Ministry of Health and Welfare.

ICD-9-CM

:   International Classification of Diseases, 9th Revision, Clinical Modification

CI

:   confidence interval

OR

:   odds ratio
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